Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/61556
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorHui, C-
dc.creatorYe, T-
dc.date.accessioned2016-12-19T08:56:18Z-
dc.date.available2016-12-19T08:56:18Z-
dc.identifier.issn2296-2646 (online)en_US
dc.identifier.urihttp://hdl.handle.net/10397/61556-
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.rightsCopyright © 2015 Hui and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.rightsThe following publication Hui C and Ye T (2015) Synthesis of lysine methyltransferase inhibitors. Front. Chem. 3:44,1-20 is available at https://dx.doi.org/10.3389/fchem.2015.00044en_US
dc.subjectEpigeneticsen_US
dc.subjectInhibitorsen_US
dc.subjectLysine methyltransferaseen_US
dc.subjectS-adenosyl-l-methionineen_US
dc.subjectSynthesisen_US
dc.titleSynthesis of lysine methyltransferase inhibitorsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1en_US
dc.identifier.epage20en_US
dc.identifier.volume3en_US
dc.identifier.doi10.3389/fchem.2015.00044en_US
dcterms.abstractLysine methyltransferase which catalyze methylation of histone and non-histone proteins, play a crucial role in diverse biological processes and has emerged as a promising target for the development of various human diseases, including cancer, inflammation, and psychiatric disorders. However, inhibiting lysine methyltransferases selectively has presented many challenges to medicinal chemists. During the past decade, lysine methyltransferase inhibitors covering many different structural classes have been designed and developed. In this review, we describe the development of selective, small-molecule inhibitors of lysine methyltransferases with an emphasis on their discovery and chemical synthesis. We highlight the current state of lysine methyltransferase inhibitors and discuss future directions and opportunities for lysine methyltransferase inhibitor discovery.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationFrontiers in chemistry, 23 July 2015, v. 3, 44, p. 1-20-
dcterms.isPartOfFrontiers in chemistry-
dcterms.issued2015-07-23-
dc.identifier.isiWOS:000373363200001-
dc.identifier.scopus2-s2.0-84969579998-
dc.identifier.pmid26258118-
dc.identifier.artn44en_US
dc.identifier.rosgroupid2015003533-
dc.description.ros2015-2016 > Academic research: refereed > Publication in refereed journalen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_IR/PIRAen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Hui_Lysine_Methyltransferase_Inhibitorse.pdf23.92 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

96
Last Week
1
Last month
Citations as of Apr 21, 2024

Downloads

83
Citations as of Apr 21, 2024

SCOPUSTM   
Citations

6
Last Week
0
Last month
Citations as of Apr 4, 2024

WEB OF SCIENCETM
Citations

7
Last Week
0
Last month
Citations as of Apr 25, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.